Basta M, Klein G J, Yee R, Krahn A, Lee J
Division of Cardiology, University of Western Ontario, London, Canada.
Cardiol Clin. 1997 Nov;15(4):587-97. doi: 10.1016/s0733-8651(05)70363-5.
Intravenous antiarrhythmic drugs will continue to have an important role in the acute management of SVT. Long-term antiarrhythmic drug therapy is often effective in preventing or reducing frequency and severity of arrhythmic episodes. The cost, adverse effects, and inconvenience of long-term drug therapy will result in the increasing use of curative ablation for most individuals with problematic SVT.
